Month: December 2021

TORONTO, Dec. 30, 2021 (GLOBE NEWSWIRE) — Gowest Gold Ltd. (“Gowest” or the “Company”) (TSX VENTURE: GWA) announced today that, following acceptance of the transaction by the TSX Venture Exchange, the Company has issued 1,503,644 shares to settle an aggregate of $240,583 of indebtedness (the “Debt Settlement”). As previously announced (see Gowest news release dated December 20, 2021), the shares were issued at a deemed price of $0.16 per share, to non-management directors of the Company, in satisfaction of director fees owing and outstanding to such individuals as of October 31, 2021. This issuance of common shares was made in order to preserve cash and improve the Company’s balance sheet. All of the securities issued in connection with the Debt Settlement are subject to a hold-period expiring four months and one day after the...

CINCINNATI, Dec. 30, 2021 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, announces that, further to its December 16, 2021 news release, its application for a management cease trade order (the “MCTO”) under National Policy 12-203 – Management Cease ‎Trade Orders (“NP 12-203”) has been approved by the British Columbia Securities Commission (“BCSC”). The MCTO does ‎not affect the ability of investors (other than management) to trade in the securities of the Company.‎ The Company announced on December 16, 2021 (the “Default Announcement”) that it was filing an application seeking a MCTO from the BCSC because ‎it was likely to miss its filing deadline of December 29, 2021 to file its annual...

Key Points:Meeting held with the US Food and Drug Administration’s (FDA) Office of Tissues and Advanced Therapies (OTAT) to address potency assay and chemistry, manufacturing and controls (CMC) items identified in the complete response letter (CRL) for remestemcel-L in the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD) in children OTAT indicated that Mesoblast’s approach to address the outstanding CMC items is reasonable OTAT indicated that the in vitro immunomodulatory activity Mesoblast intends to measure for potency is a reasonable critical quality attribute (CQA) for the product, and the relevance of this activity to clinical outcomes should be established Mesoblast has now generated substantial new data that it believes establish the relevance of the proposed in vitro immunomodulatory activity of remestemcel-L...

VANCOUVER, British Columbia, Dec. 30, 2021 (GLOBE NEWSWIRE) — NorthWest Copper (“NorthWest” or the “Company”) (TSX-V:NWST, OTCQX:NWXCC) announces that it has granted 3,575,000 Stock Options to directors, certain employees and consultants, and 1,175,000 Restricted Share Units (“RSUs”) to certain employees and consultants pursuant to its Stock Option and RSU Plans. The Stock Options have an exercise price of $0.80 and have a range of vesting periods over three years and expire after five years. The RSUs are payable in common shares of the Company on exercise, have a range of vesting periods over three years and must be redeemed within 30 days of December 29, 2024, or they expire. About NorthWest Copper: NorthWest is a new copper-gold explorer and developer with an exciting pipeline of projects in British Columbia. With a robust portfolio...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES (All figures in Canadian dollars unless otherwise stated) TORONTO, Dec. 30, 2021 (GLOBE NEWSWIRE) — Q-Gold Resources Ltd (TSXV: QGR, OTC: QGLDF, FRA: QX9G) (“Q-Gold” or the “Company”) is pleased to announce it is initiating a non-brokered flow-through financing (the “Offering”). The Offering will consist of up to of 9,090,910 flow-through units (within the meaning of subsection 66(15) of the Income Tax Act (Canada)) priced at $0.11 per flow-through unit (the “Offering Price”) for gross proceeds of up to $1,000,000. Each flow-through unit will consist of one flow-through common share of the Company and one-half non-flow-through share purchase warrant. Each whole warrant will entitle the holder to acquire one common share of the Company...

TORONTO, Dec. 30, 2021 (GLOBE NEWSWIRE) — Honey Badger Silver Inc. (TSX-V: TUF) (“Honey Badger Silver” or the “Company”) announces that the Board of Directors has approved the grant of stock options to directors, officers, employees and consultants of the Company for the purchase of up to 4,809,800 shares in the Company exercisable at a price of $0.075 for a period of five years from the date of grant. The grant is pursuant and subject to the terms and conditions of the Company’s existing stock option plan and is subject to the approval of the TSX Venture Exchange and all regulatory requirements. ON BEHALF OF THE BOARD Chad WilliamsExecutive Chairman and Director About Honey Badger Silver Inc. Honey Badger Silver is a Canadian Silver company based in Toronto, Ontario focused on the acquisition, development and integration of accretive...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 30, 2021 (GLOBE NEWSWIRE) — Jourdan Resources Inc. (TSX-V: JOR) (“Jourdan” or the “Company”) announces that it intends to complete a best efforts non-brokered private placement flow-through financing of up to 40,000,000 units (each, a “Unit”) at a price of $0.05 per Unit for gross proceeds of up to $2,000,000 (the “Offering”). Each Unit will be issued on a “flow-through basis” and will consist of one common share of the Company and one-half of one common share purchase warrant (each whole warrant, a “Warrant”). Each Warrant entitles the holder to acquire one additional common share of the Company at an exercise price of $0.08 for a period of 24 months from issuance. Closing of the Offering is expected to occur on or about...

CHARLOTTE, N.C., Dec. 30, 2021 (GLOBE NEWSWIRE) — DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) announced today that the Company will participate virtually in the 40th Annual J.P. Morgan Healthcare Conference. Don Casey, Chief Executive Officer, is scheduled to present on Wednesday, January 12, 2022 at 11:15 am ET. A live audio webcast and presentation materials will be available through the Investors section of the Dentsply Sirona website at https://investor.dentsplysirona.com. A replay of the webcast will be available for 30 days following the presentation. About Dentsply Sirona Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with a 134-year history of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and...